Heilig C W, Brosius F C, Henry D N
University of Rochester School of Medicine, Nephrology Unit, New York, USA.
Kidney Int Suppl. 1997 Sep;60:S91-9.
Several glucose transporters have recently been identified in glomeruli, and in cultured glomerular cells. These include the facilitative glucose transporter isoforms GLUTs 1, 3 and 4, and sodium-glucose cotransport activity with characteristics of SGLT1. GLUTs 1, 3 and 4 are all high affinity, low capacity, facilitative glucose transporters which typically would be saturated at or near physiologic glucose concentrations. The SGLT transporter of mesangial cells is also a high affinity transporter which similarly could be saturated under normal glucose conditions. This suggests that in order for mesangial cells to take up excessive quantities of glucose in diabetes, changes in glucose transporter expression, translocation or activity may be required. Accordingly, recent investigations discovered positive-feedback regulation of the mesangial cell GLUT1 transporter by glucose, and a regulatory role for GLUT1 in glucose metabolism and extracellular matrix synthesis. Future investigations of glucose transporters in the pathogenesis of diabetic renal disease will now likely proceed in multiple directions, including but not limited to: (1) examination of their regulation by growth factors implicated in diabetic nephropathy, and the resultant effects on ECM synthesis; (2) determination of the mechanisms by which GLUT1 regulates the expression of aldose reductase, PKC, GLUT1, and other genes in the mesangial cell; and (3) Suppression of glucose transporters in attempts to prevent high glucose-induced diabetic glomerulosclerosis.
最近在肾小球及培养的肾小球细胞中发现了几种葡萄糖转运蛋白。这些包括易化型葡萄糖转运蛋白异构体GLUT1、GLUT3和GLUT4,以及具有SGLT1特征的钠-葡萄糖协同转运活性。GLUT1、GLUT3和GLUT4均为高亲和力、低容量的易化型葡萄糖转运蛋白,通常在生理葡萄糖浓度或接近生理葡萄糖浓度时达到饱和。系膜细胞的SGLT转运蛋白也是一种高亲和力转运蛋白,在正常葡萄糖条件下同样可能达到饱和。这表明,为了使系膜细胞在糖尿病时摄取过量葡萄糖,可能需要葡萄糖转运蛋白的表达、易位或活性发生改变。因此,最近的研究发现葡萄糖对系膜细胞GLUT1转运蛋白具有正反馈调节作用,且GLUT1在葡萄糖代谢和细胞外基质合成中具有调节作用。现在,关于葡萄糖转运蛋白在糖尿病肾病发病机制中的未来研究可能会朝着多个方向进行,包括但不限于:(1)研究糖尿病肾病相关生长因子对其的调节作用以及对细胞外基质合成的最终影响;(2)确定GLUT1调节系膜细胞中醛糖还原酶、蛋白激酶C、GLUT1和其他基因表达的机制;(3)抑制葡萄糖转运蛋白以试图预防高糖诱导的糖尿病肾小球硬化。